KRAS, NRAS,BRAF Mutation Testing in Republic of Korea — Get 3 Top Clinic Matches with Costs

Dr. Jung Sang Jin is a Clinical Professor of Orthopedic Surgery at Myongji Hospital, an educational partner of Hanyang University. He specializes in joint replacement, knee conditions, lower-extremity trauma, diabetic foot, arthritis, and osteoporosis.

He earned his MD and MSc from Konyang University. He completed his internship and orthopedic residency at Konyang University Hospital. He then finished a hip and knee arthroplasty clinical fellowship at Samsung Medical Center. He also completed AO Recon advanced arthroplasty training in Davos. In addition, he finished the AO Trauma Masters and AO Recon Hip and Knee courses. He is a member of the Korean Orthopaedic Association, Korean Knee Society, Korean Fracture Society, Korean Society of Sports Medicine, Korean Hip Society, and AO Trauma and AO Recon. He has published on hip replacement outcomes. He received a KOA poster award in 2023.

Dr. Hyuk‑Jai Shin, MD, PhD, is a Clinical Professor of Surgery at Myongji Hospital in South Korea. He is also Director of the Breast Center and Vice President for Medical Affairs. His work focuses on breast cancer, benign breast disease, robotic and endoscopic breast surgery, and systemic therapy. He chairs the Korean Breast Cancer Society group for robotic and endoscopic minimally invasive surgery. He is a full member of ASCO.

He earned his MD and PhD from Dankook University. He completed a breast fellowship and served as a principal proteomics researcher at Seoul National University Hospital. He received endoscopic training at Kameda Hospital in Japan. He was an exchange professor at the University of Melbourne and a visiting surgeon at the Peter MacCallum Cancer Centre. He previously led the Breast & Thyroid Center and the Precision Medicine Center at Myongji Hospital. His publications include first‑author chapters in Translational Research in Breast Cancer (Chapter 30, pp. 567–590, Springer) and the Textbook of Surgical Ultrasound (Chapter 3‑3, VABB). He also co‑authored a nationwide VABB survey (Anticancer Research, 2012; 32(12):5459–64).